The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives

Objectives We have investigated whether the A1166C polymorphism of the angiotensin II type 1 (AT1) receptor gene modulates the effects of angiotensin II on collagen type I turnover and myocardial stiffness in hypertension. Methods We studied 255 hypertensive patients before and after 1 year of treatment with either losartan (n = 185) or atenolol (n = 70). Serum concentrations of the carboxy-terminal propeptide of procollagen type I (PIP) and the carboxy-terminal telopeptide of collagen type I (CITP), markers of extracellular collagen type I synthesis and degradation, respectively, were measured by specific radioimmunoassays. Left ventricular chamber stiffness (KLV), was determined from the deceleration time of the early mitral filling wave, as measured by Doppler echocardiography. Hypertensives were genotyped by polymerase chain reaction and divided in two subgroups: AA (n = 126) and AC/CC (n = 129). Results Baseline PIP and KLV were increased (P < 0.01) in AA hypertensives compared with AC/CC hypertensives. No changes in baseline CITP were observed between the two subgroups of hypertensives. Confounding factors were similar between the two subgroups of hypertensives. Administration of losartan was associated with reduction (P < 0.01) in PIP and KLV in AA hypertensives but not in AC/CC hypertensives. Treatment with atenolol did not change PIP and KLV in either subgroup of hypertensives. No changes in CITP were observed with the two treatments. Conclusion These findings suggest that the A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in patients with hypertensive heart disease.

[1]  Arantxa González,et al.  Clinical aspects of hypertensive myocardial fibrosis , 2001, Current opinion in cardiology.

[2]  F. Cambien,et al.  Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. , 1996, Circulation.

[3]  K. Weber,et al.  Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis. , 1996, Hypertension.

[4]  M. Quiñones,et al.  Percentage of shortening of the echocardiographic left ventricular dimension. Its use in determining ejection fraction and stroke volume. , 1978, Chest.

[5]  J. Díez,et al.  Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. , 1995, Circulation.

[6]  H. Crijns,et al.  Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. , 2000, Hypertension.

[7]  L. Tiret,et al.  Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. , 1994, Hypertension.

[8]  M Ishii,et al.  [The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, and 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension]. , 2000, Nihon rinsho. Japanese journal of clinical medicine.

[9]  J. Laragh,et al.  Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. , 1992, Journal of the American College of Cardiology.

[10]  B. Strauer,et al.  Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. , 1993, Circulation.

[11]  Arantxa González,et al.  Biochemical assessment of myocardial fibrosis in hypertensive heart disease. , 2001, Hypertension.

[12]  R L Popp,et al.  Relation of Transmitral Flow Velocity Patterns to Left Ventricle Diastolic Function: New Insights From a Combined Hemodynamic and Doppler Echocardiographic Study , 1988, Journal of the American College of Cardiology.

[13]  Lippincott Williams Wilkins,et al.  1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. , 1993, Hypertension.

[14]  K. Berg,et al.  Polymorphisms at the angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) loci and normal blood pressure , 1998, Clinical genetics.

[15]  B. Morris,et al.  Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension , 1997, Clinical genetics.

[16]  F. Cambien,et al.  Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals. , 1996, Hypertension.

[17]  A. Hingorani,et al.  A simple molecular assay for the C1166 variant of the angiotensin II type 1 receptor gene. , 1995, Biochemical and biophysical research communications.

[18]  D. Prockop,et al.  Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen proteinases. , 1982, The Journal of biological chemistry.

[19]  Arantxa González,et al.  Losartan-Dependent Regression of Myocardial Fibrosis Is Associated With Reduction of Left Ventricular Chamber Stiffness in Hypertensive Patients , 2002, Circulation.

[20]  N. Liyou,et al.  THE A1166C MUTATION IN THE ANGIOTENSIN II TYPE I RECEPTOR AND HYPERTENSION IN THE ELDERLY , 1999, Clinical and experimental pharmacology & physiology.

[21]  Jean Tichet,et al.  Gene polymorphisms of the renin‐angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study , 1998, Journal of hypertension.

[22]  Arantxa González,et al.  Regulation of myocardial fibrillar collagen by angiotensin II. A role in hypertensive heart disease? , 2002, Journal of molecular and cellular cardiology.

[23]  L. Peltonen,et al.  Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. , 1999, Hypertension.

[24]  J. Díez,et al.  Abnormalities of the extracellular degradation of collagen type I in essential hypertension. , 1998, Circulation.

[25]  J. Risteli,et al.  Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. , 1993, Clinical chemistry.

[26]  N. Smedira,et al.  Estimation of left ventricular operating stiffness from Doppler early filling deceleration time in humans. , 2001, American journal of physiology. Heart and circulatory physiology.

[27]  J. Díez,et al.  Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats. , 1995, American journal of hypertension.

[28]  Arantxa González,et al.  Usefulness of Serum Carboxy-Terminal Propeptide of Procollagen Type I in Assessment of the Cardioreparative Ability of Antihypertensive Treatment in Hypertensive Patients , 2001, Circulation.

[29]  P. Poole‐Wilson.  Heart failure : scientific principles and clinical practice , 1997 .

[30]  W. Spiering,et al.  Angiotensin II Sensitivity Is Associated With the Angiotensin II Type 1 Receptor A1166C Polymorphism in Essential Hypertensives on a High Sodium Diet , 2000, Hypertension.

[31]  H. Melhus,et al.  Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial , 2002, Journal of hypertension.

[32]  A. Fishman,et al.  Muscle fiber orientation and connective tissue content in the hypertrophied human heart. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[33]  F. Cambien,et al.  Angiotensin II type 1 receptor−153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects , 2001, Journal of hypertension.

[34]  B. Strauer,et al.  Structural analysis of arteriolar and myocardial remodelling in the subendocardial region of patients with hypertensive heart disease and hypertrophic cardiomyopathy , 1997, Virchows Archiv.

[35]  J. Emparanza,et al.  Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. , 2000, Circulation.

[36]  G. Laurent,et al.  Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. , 1987, The American journal of physiology.

[37]  H. Melhus,et al.  Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients , 2001, Journal of hypertension.

[38]  M. Pfeffer,et al.  Cardiac function and morphology with aging in the spontaneously hypertensive rat. , 1979, The American journal of physiology.

[39]  J. Ross,et al.  Development and regression of left ventricular hypertrophy. , 1984, Journal of the American College of Cardiology.

[40]  Mario J. Garcia,et al.  New Doppler echocardiographic applications for the study of diastolic function. , 1998, Journal of the American College of Cardiology.